原題
Five-Year Survival with Tebentafusp in Metastatic Uveal Melanoma.
Journal: Ann Oncol (CiteScore 2022: 63)
DOI: 10.1016/j.annonc.2026.05.695
PMID: 42162665
melanoma原題
Five-Year Survival with Tebentafusp in Metastatic Uveal Melanoma.
Journal: Ann Oncol (CiteScore 2022: 63)
DOI: 10.1016/j.annonc.2026.05.695
PMID: 42162665
コメント